1. HBW Insight
  2. >>Health
  3. >>Rx-to-OTC Switch

In AstraZeneca-Sponsored Study, Digital App Corrects OTC Statin Self-Selection Problem

Study Also Could Improve Chances In US To Switch Drugs For Other Chronic Conditions

 
• By Eileen Francis and Malcolm Spicer

Using web app for self-selection was successful with more than 95% concordance for the primary endpoint comparing results obtained by participants and independent clinical assessments, say researchers led by cardiologist and consumer health innovation advocate Steven Nissen.

Comparison of technology-assisted self-selection outcomes obtained by participants and clinicians at research sites in study of consumers' OTC access to Crestor. • Source: Journal of the American College of Cardiology

The chances for OTC switch proposals for statins in the US could improve based on results of a study funded by AstraZeneca PLC showing consumers using an online tool appropriately self-selected the firm's Crestor.

The study published recently in the Journal of the American College of Cardiology also could be a bellwether for switch applications for other types of drugs for chronic health conditions...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rx-to-OTC Switch

More from Health